Brought to you by 
Catabasis gets initial $7.7mm in Series A round; adds $14.5mm
13 Dec 2011
Executive Summary
Catabasis Pharmaceuticals Inc. (developing therapeutics for inflammatory and metabolic disorders) has raised $7.7mm out of a potential $39.7mm in its Series A financing led by SV Life Sciences, Clarus Ventures, and MedImmune Ventures, which all add a board member. Advanced Technology Ventures and 11 other investors also participated.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com